168 related articles for article (PubMed ID: 31886273)
21. Prognostic significance of FAM3C in esophageal squamous cell carcinoma.
Zhu YH; Zhang B; Li M; Huang P; Sun J; Fu J; Guan XY
Diagn Pathol; 2015 Oct; 10():192. PubMed ID: 26498278
[TBL] [Abstract][Full Text] [Related]
22. The tumor-suppressive role of BATF2 in esophageal squamous cell carcinoma.
Han T; Wang Z; Yang Y; Shu T; Li W; Liu D; Li P; Qi R; Ren Y; Li L; Liu H; Zhang S; Zhang L
Oncol Rep; 2015 Sep; 34(3):1353-60. PubMed ID: 26135942
[TBL] [Abstract][Full Text] [Related]
23. Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma.
Dong Z; Liang X; Wu X; Kang X; Guo Y; Shen S; Liang J; Guo W
Clin Exp Metastasis; 2019 Jun; 36(3):225-241. PubMed ID: 30915595
[TBL] [Abstract][Full Text] [Related]
24. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.
Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT
Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575
[TBL] [Abstract][Full Text] [Related]
25. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of CDK6 amplification in esophageal squamous cell carcinoma.
Liu K; Lu H; Jiang D; Guan Y; Xu H; Sun Q; Jiang Q; Zheng J; Chen H; Zhang F; Luo R; Huang Y; Xu J; Hou Y
Cancer Treat Res Commun; 2023; 35():100698. PubMed ID: 37023643
[TBL] [Abstract][Full Text] [Related]
27. Poor prognostic impact of FGF4 amplification in patients with esophageal squamous cell carcinoma.
Huang J; Song Q; Wang H; Wang H; Xu C; Wang X; Jiang Z; Wang Y; Xu Y; Su J; Zeng H; Tan L; Zhu H; Jiang D; Hou Y
Hum Pathol; 2018 Oct; 80():210-218. PubMed ID: 29936056
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Significance of c-MYC Amplification in Esophageal Squamous Cell Carcinoma.
Huang J; Jiang D; Zhu T; Wang Y; Wang H; Wang Q; Tan L; Zhu H; Yao J; Hou Y
Ann Thorac Surg; 2019 Feb; 107(2):436-443. PubMed ID: 30273571
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA LINC01296 is associated with poor prognosis in ESCC and promotes ESCC cell proliferation, migration and invasion.
Wang B; Liang T; Li J
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4524-4531. PubMed ID: 30058683
[TBL] [Abstract][Full Text] [Related]
30. Systematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinoma.
Xu J; Zhu C; Yu Y; Wu W; Cao J; Li Z; Dai J; Wang C; Tang Y; Zhu Q; Wang J; Wen W; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; He Z; Pan X; Wei H; Zhu Y; He Y; Que J; Luo J; Chen L; Wang W
EBioMedicine; 2019 Aug; 46():54-65. PubMed ID: 31324603
[TBL] [Abstract][Full Text] [Related]
31. Elevated preoperative platelet distribution width predicts poor prognosis in Esophageal Squamous Cell Carcinoma.
Song Q; Wu JZ; Wang S; Chen WH
Sci Rep; 2019 Oct; 9(1):15234. PubMed ID: 31645619
[TBL] [Abstract][Full Text] [Related]
32. A Novel Clinical Six-Flavoprotein-Gene Signature Predicts Prognosis in Esophageal Squamous Cell Carcinoma.
Peng L; Guo JC; Long L; Pan F; Zhao JM; Xu LY; Li EM
Biomed Res Int; 2019; 2019():3869825. PubMed ID: 31815134
[TBL] [Abstract][Full Text] [Related]
33. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis.
Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z
Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of PAX9 in patients with esophageal squamous cell carcinoma and its prediction value to radiation sensitivity.
Tan B; Wang J; Song Q; Wang N; Jia Y; Wang C; Yao B; Liu Z; Zhang X; Cheng Y
Mol Med Rep; 2017 Jul; 16(1):806-816. PubMed ID: 28560390
[TBL] [Abstract][Full Text] [Related]
35. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
[TBL] [Abstract][Full Text] [Related]
36. TAB3 promotes human esophageal squamous cell carcinoma proliferation and invasion via the NF‑κB pathway.
Zhao J; Gai L; Gao Y; Xia W; Shen D; Lin Q; Mao W; Wang F; Liu P; Chen J
Oncol Rep; 2018 Nov; 40(5):2876-2885. PubMed ID: 30226617
[TBL] [Abstract][Full Text] [Related]
37. KIF-2C expression is correlated with poor prognosis of operable esophageal squamous cell carcinoma male patients.
Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Fu XY; Ma QL; Wang XY; Lin P
Oncotarget; 2016 Dec; 7(49):80493-80507. PubMed ID: 27563815
[TBL] [Abstract][Full Text] [Related]
38. Serum microRNA-15a level acts as a potential diagnostic and prognostic biomarker for human esophageal squamous cell carcinoma.
Li J; Li M; Gao F; Ge X
Cancer Biomark; 2017; 18(1):11-17. PubMed ID: 27802201
[TBL] [Abstract][Full Text] [Related]
39. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
Liu L; Yang Z; Ni W; Xuan Y
Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
[TBL] [Abstract][Full Text] [Related]
40. H3K9me3, H3K36me3, and H4K20me3 Expression Correlates with Patient Outcome in Esophageal Squamous Cell Carcinoma as Epigenetic Markers.
Zhou M; Li Y; Lin S; Chen Y; Qian Y; Zhao Z; Fan H
Dig Dis Sci; 2019 Aug; 64(8):2147-2157. PubMed ID: 30788686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
